☆ 4.8 Article

Immunogenicity of a vaccinia virus-based severe acute respiratory syndrome coronavirus 2 vaccine candidate

FRONTIERS IN IMMUNOLOGY (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Biotechnology & Applied Microbiology

Single-dose replicating poxvirus vector-based RBD vaccine drives robust humoral and T cell immune response against SARS-CoV-2 infection

Stephen Boulton et al.

Summary: This study evaluates the effects of dose escalation and administration routes on vaccine safety, efficacy, and immunogenicity in animal models. The developed vaccine platform shows robust immune responses and protective immunity against SARS-CoV-2 variants, offering an alternative or complementary approach to current vaccines.

MOLECULAR THERAPY (2022)

添加到收藏夹

Article Infectious Diseases

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial

Shengli Xia et al.

Summary: The inactivated SARS-CoV-2 vaccine, BBIBP-CorV, demonstrated safety and immunogenicity in two age groups. Humoral responses against SARS-CoV-2 were induced in all vaccine recipients by day 42. A two-dose immunisation with 4 mu g vaccine on days 0 and 21 or days 0 and 28 achieved higher neutralising antibody titres compared to other dosing schedules.

LANCET INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Virology

COVID-19 Vaccine Candidates Based on Modified Vaccinia Virus Ankara Expressing the SARS-CoV-2 Spike Protein Induce Robust T- and B-Cell Immune Responses and Full Efficacy in Mice

Juan Garcia-Arriaza et al.

Summary: Two COVID-19 vaccines based on MVA vectors induced robust and polyfunctional T-cell responses and neutralizing antibody titers in mice, providing protection against SARS-CoV-2. The results demonstrate the full efficacy of MVA-based COVID-19 vaccines in animal models and support their translation to clinical use.

JOURNAL OF VIROLOGY (2021)

添加到收藏夹

Correction Multidisciplinary Sciences

ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques (vol 586, pg 578, 2020)

Neeltje van Doremalen et al.

NATURE (2021)

添加到收藏夹

Correction Multidisciplinary Sciences

A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity (vol 586, pg 572, 2020)

Jingyun Yang et al.

Summary: A correction to this paper has been published.

NATURE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate

Lorena Sanchez-Felipe et al.

Summary: The candidate vaccine YF-S0, utilizing the YF17D vaccine as a vector to express noncleavable prefusion form of the SARS-CoV-2 spike antigen, showed excellent safety, immunogenicity, and efficacy in animal models. It induced high levels of neutralizing antibodies, provided protective immunity against SARS-CoV-2, and prevented infection in hamsters and macaques. A single dose was able to confer protection from lung disease in most vaccinated hamsters within 10 days, highlighting the potential of YF-S0 as a potent SARS-CoV-2 vaccine candidate.

NATURE (2021)

添加到收藏夹

Article Immunology

A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs

Nanda Kishore Routhu et al.

Summary: The study demonstrates that MVA/S vaccination induces strong neutralizing antibody and T cell responses, providing protection against SARS-CoV-2 in mice and macaques. Single-cell RNA sequencing analysis of lung cells reveals that the vaccination also protects macaques from infection-induced inflammation and B cell abnormalities.

IMMUNITY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Rapid assessment of SARS-CoV-2-evolved variants using virus-like particles

Abdullah M. Syed et al.

Summary: Efforts to determine the improved fitness of new SARS-CoV-2 variants have been limited to analyzing spike protein mutations. This study shows that SC2-VLPs can deliver exogenous transcripts, allowing analysis of mutations in all structural proteins. Specific nucleocapsid mutations were found to independently increase messenger RNA delivery and expression, shedding light on mechanisms behind the increased spread of variants.

SCIENCE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

One or two injections of MVA-vectored vaccine shields hACE2 transgenic mice from SARS-CoV-2 upper and lower respiratory tract infection

Ruikang Liu et al.

Summary: Research on modified vaccinia virus Ankara (MVA) expressing the S protein of SARS-CoV-2 showed promising results in inducing antibodies and CD8+ T cells, protecting transgenic mice from lethal infection, preventing nasal infection, reducing cytokine expression, and effectively terminating virus replication in vaccinated animals.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

添加到收藏夹

Article Immunology

Intranasal administration of a recombinant RBD vaccine induced protective immunity against SARS-CoV-2 in mouse

Yingying Du et al.

Summary: This study compared immune responses of a SARS-CoV-2 RBD-based subunit vaccine in mice after administration via different routes, showing that intranasal delivery elicited robust systemic and mucosal immunity, suggesting the potential importance of intranasal administration for future SARS-CoV-2 vaccine design.

VACCINE (2021)

添加到收藏夹

Article Immunology

Localized and Systemic Immune Responses against SARS-CoV-2 Following Mucosal Immunization

Shaswath S. Chandrasekar et al.

Summary: The study demonstrated that using a heterologous immunization strategy can induce neutralizing antibodies against SARS-CoV-2 in mice, showing potential for a protective vaccine. This approach also induced polyfunctional T-cell responses, while the homologous plasmid vaccine strategy mainly led to local T-cell responses.

VACCINES (2021)

添加到收藏夹

Article Immunology

Intranasal Delivery of MVA Vector Vaccine Induces Effective Pulmonary Immunity Against SARS-CoV-2 in Rodents

Berislav Bosnjak et al.

Summary: The study demonstrates that intranasal delivery of MVA-SARS-2-S effectively induces pulmonary spike-specific CD8(+) T cells, albeit with restricted production of neutralizing antibodies. Intranasal booster vaccine delivery is crucial for massive expansion of spike-specific CD8(+) T cells in systemic and lung tissues, as well as the development of Th1 - but not Th2 - CD4(+) T cells, with high levels of IgG and IgA anti-spike antibodies capable of neutralizing all current SARS-CoV-2 variants of concern.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Article Immunology

MVA vector expression of SARS-CoV-2 spike protein and protection of adult Syrian hamsters against SARS-CoV-2 challenge

Clement A. Meseda et al.

Summary: Using MVA vectors expressing SARS-CoV-2 S as vaccines provides protection in adult Syrian hamsters, demonstrating the utility of this animal model in evaluating candidate SARS-CoV-2 vaccines.

NPJ VACCINES (2021)

添加到收藏夹

Article Immunology

Mucosal vaccination induces protection against SARS-CoV-2 in the absence of detectable neutralizing antibodies

Chaojie Zhong et al.

Summary: The candidate multigenic SARS-CoV-2 vaccine based on an MVA vector expressing viral N and S proteins induced T-cell responses and binding antibodies, but not neutralizing antibodies. Intranasal immunization with the vaccine reduced viral loads and lung inflammation in mice after SARS-CoV-2 challenge, correlated with T-cell response in the lung, indicating the importance of T-cell immunity for protection against SARS-CoV-2 infection in addition to neutralizing antibodies.

NPJ VACCINES (2021)

添加到收藏夹

Article Immunology

Cellular and Humoral Immune Responses in Mice Immunized with Vaccinia Virus Expressing the SARS-CoV-2 Spike Protein

Jake C. Harbour et al.

Summary: This study used a recombinant Vaccinia virus expressing the full-length spike protein of SARS-CoV-2 to evaluate the immune response in mice. It was found that both cellular and humoral immune responses targeted the S1 domain of the spike protein strongly, suggesting the potential of this approach for further vaccine development against COVID-19.

JOURNAL OF IMMUNOLOGY (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19

Brian J. Ward et al.

Summary: This study reported the interim safety and immunogenicity data of a plant-produced COVID-19 vaccine candidate at Day 42. The results showed good tolerability of all formulations and induction of immune responses, supporting further evaluation of the vaccine candidate.

NATURE MEDICINE (2021)

添加到收藏夹

Article Microbiology

Inactivated rabies virus vectored SARS-CoV-2 vaccine prevents disease in a Syrian hamster model

Drishya Kurup et al.

Summary: The study developed an inactivated rabies virus vectored vaccine platform, resulting in a vaccine against SARS-CoV-2 named CORAVAX. CORAVAX demonstrated effectiveness in preventing viral replication and lung disease in hamster models, showing potential for robust immune responses in humans.

PLOS PATHOGENS (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Vaccinia virus-based vaccines confer protective immunity against SARS-CoV-2 virus in Syrian hamsters

Rakesh Kulkarni et al.

Summary: SARS-CoV-2 causes severe illness and mortality, highlighting the urgent need for vaccines. The development of stable lyophilized vaccines is crucial for global vaccination to combat the virus and potential variants. Additionally, promising candidate vaccines based on viral strains have shown to induce strong immune responses in animal models, providing hope for future development.

PLOS ONE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination

Alina Tscherne et al.

Summary: The SARS-CoV-2 virus has caused the COVID-19 pandemic, and a recombinant MVA expressing the SARS-CoV-2 spike protein shows promise as a candidate for developing a COVID-19 vaccine.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Protection of K18-hACE2 mice and ferrets against SARS-CoV-2 challenge by a single-dose mucosal immunization with a parainfluenza virus 5-based COVID-19 vaccine

Dong An et al.

Summary: This mucosal vaccine strategy inhibits SARS-CoV-2 replication in the upper respiratory tract, preventing disease transmission. The vaccine candidate CVXGA1 shows promising protective effects in animal models.

SCIENCE ADVANCES (2021)

添加到收藏夹

Article Multidisciplinary Sciences

DNA vaccine protection against SARS-CoV-2 in rhesus macaques

Jingyou Yu et al.

SCIENCE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Immunogenicity of a DNA vaccine candidate for COVID-19

Trevor R. F. Smith et al.

NATURE COMMUNICATIONS (2020)

添加到收藏夹

Article Medicine, General & Internal

Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial

Feng-Cai Zhu et al.

LANCET (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2

Hui Wang et al.

CELL (2020)

添加到收藏夹

Article Microbiology

Replication-Competent Vesicular Stomatitis Virus Vaccine Vector Protects against SARS-CoV-2-Mediated Pathogenesis in Mice

James Brett Case et al.

CELL HOST & MICROBE (2020)

添加到收藏夹

Article Medicine, General & Internal

Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes Interim Analysis of 2 Randomized Clinical Trials

Shengli Xia et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

添加到收藏夹

Article Medicine, General & Internal

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Pedro M. Folegatti et al.

LANCET (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques

Noe B. Mercado et al.

NATURE (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters

Lisa H. Tostanoski et al.

NATURE MEDICINE (2020)

添加到收藏夹

Article Medicine, General & Internal

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial

Maheshi N. Ramasamy et al.

LANCET (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Development of a multi-antigenic SARS-CoV-2 vaccine candidate using a synthetic poxvirus platform

Flavia Chiuppesi et al.

NATURE COMMUNICATIONS (2020)

添加到收藏夹

Article Immunology

Establishment of replication-competent vesicular stomatitis virus-based recombinant viruses suitable for SARS-CoV-2 entry and neutralization assays

Hongyue Li et al.

EMERGING MICROBES & INFECTIONS (2020)

添加到收藏夹

Article Immunology

Intranasal immunization with recombinant Vaccinia virus Tiantan harboring Zaire Ebola virus gp elicited systemic and mucosal neutralizing antibody in mice

Lilan Xie et al.

VACCINE (2019)

添加到收藏夹

Article Pharmacology & Pharmacy

Improved immune response against HIV-1 Env antigen by enhancing EEV production via a K151E mutation in the A34R gene of replication-competent vaccinia virus Tiantan

Jie Yu et al.

ANTIVIRAL RESEARCH (2018)

添加到收藏夹

Article Immunology

Recombinant vaccinia vector-based vaccine (Tiantan) boosting a novel HBV subunit vaccine induced more robust and lasting immunity in rhesus macaques

Yao Deng et al.

VACCINE (2017)

添加到收藏夹

Article Immunology

Immunological Characterization of a Modified Vaccinia Virus Ankara Vector Expressing the Human Papillomavirus 16 E1 Protein

Christelle Remy-Ziller et al.

CLINICAL AND VACCINE IMMUNOLOGY (2014)

添加到收藏夹

Article Multidisciplinary Sciences

Evaluation of a New Recombinant Oncolytic Vaccinia Virus Strain GLV-5b451 for Feline Mammary Carcinoma Therapy

Marion Adelfinger et al.

PLOS ONE (2014)

添加到收藏夹

Article Biotechnology & Applied Microbiology

The Novel Replication-defective Vaccinia Virus (Tiantan Strain)-based Hepatitis C Virus Vaccine Induces Robust Immunity in Macaques

Bo Wen et al.

MOLECULAR THERAPY (2013)

添加到收藏夹

Article Multidisciplinary Sciences

Improving Adaptive and Memory Immune Responses of an HIV/AIDS Vaccine Candidate MVA-B by Deletion of Vaccinia Virus Genes (C6L and K7R) Blocking Interferon Signaling Pathways

Juan Garcia-Arriaza et al.

PLOS ONE (2013)

添加到收藏夹

Article Multidisciplinary Sciences

Genomic Sequence and Virulence of Clonal Isolates of Vaccinia Virus Tiantan, the Chinese Smallpox Vaccine Strain

Qicheng Zhang et al.

PLOS ONE (2013)

添加到收藏夹

Article Multidisciplinary Sciences

A Replicating Modified Vaccinia Tiantan Strain Expressing an Avian-Derived Influenza H5N1 Hemagglutinin Induce Broadly Neutralizing Antibodies and Cross-Clade Protective Immunity in Mice

Haixia Xiao et al.

PLOS ONE (2013)

添加到收藏夹

Article Immunology

Biological Properties of H5 Hemagglutinin Expressed by Vaccinia Virus Vector and its Immunological Reactivity with Human Sera

Pirom Noisumdaeng et al.

VIRAL IMMUNOLOGY (2013)

添加到收藏夹

Article Multidisciplinary Sciences

Optimisation of Prime-Boost Immunization in Mice Using Novel Protein-Based and Recombinant Vaccinia (Tiantan)-Based HBV Vaccine

Hong Chen et al.

PLOS ONE (2012)

添加到收藏夹

Article Immunology

Broad HIV-1 neutralizing antibody response induced by heterologous gp140/gp145 DNA prime-vaccinia boost immunization

Lianxing Liu et al.

VACCINE (2012)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Mucosal Immunization Induces a Higher Level of Lasting Neutralizing Antibody Response in Mice by a Replication-Competent Smallpox Vaccine: Vaccinia Tiantan Strain

Bin Lu et al.

JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)

添加到收藏夹

Article Biochemistry & Molecular Biology

Duration of antiviral immunity after smallpox vaccination

E Hammarlund et al.

NATURE MEDICINE (2003)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.